新加坡2型糖尿病中与糖尿病视网膜病变严重程度相关的直接医疗成本

数据集获取（Figshare）

• 源站标题：Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore
• DOI：10.1371/journal.pone.0180949
• 发布日期：2017-07-10
• 文件数：2 个
• 文件总体积：33.20 KB
• 源站页面：https://plos.figshare.com/articles/dataset/Direct_medical_cost_associated_with_diabetic_retinopathy_severity_in_type_2_diabetes_in_Singapore/5192446

命令行下载

curl -L -o "S1 Table.docx" "https://ndownloader.figshare.com/files/8864047"
curl -L -o "S2 Table.docx" "https://ndownloader.figshare.com/files/8864053"

文件清单

• S1 Table.docx（17.75 KB）
• S2 Table.docx（15.45 KB）

文件总体积 33.20 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Diabetic retinopathy (DR) is a leading cause of vision-loss globally among type 2 diabetes (T2DM) patients. Information on the economic burden of DR in Singapore is limited. We aim to identify the total annual direct medical costs of DR at different stages, and to examine factors influencing the costs. Four hundreds and seventy T2DM patients who attended the Diabetes Centre in a secondary hospital in Singapore in 2011–2014 were included. Digital color fundus photographs were assessed for DR in a masked fashion. Retinopathy severity was further categorized into non-proliferative DR (NPDR), including mild, moderate and severe NPDR, and proliferative DR (PDR). Medical costs were assessed using hospital administrative data. DR was diagnosed in 172 (39.5%) patients, including 51 mild, 62 moderate and 18 severe NPDR, and 41 PDR. The median cost in DR [2012.0 (1111.2–4192.3)] was significantly higher than that in non-DR patients [1158.1 (724.1–1838.9)] (p<0.001). The corresponding costs for mild, moderate, severe NPDR and PDR were [1167.1 (895.4–2012.0)], [2212.0 (1215.5–3825.5)], [2717.5 (1444.0–6310.7)], and [3594.8.1 (1978.4–8427.7)], respectively. After adjustment, the corresponding cost ratios for mild, moderate, severe NPDR, and PDR relative to non-DR were 1.1 (p = 0.827), 1.8 (p = 0.003), 2.0 (p = 0.031) and 2.3 (p<0.001), respectively. The other factors affecting the total cost include smoking (ratio = 1.7, p = 0.019), neuropathy (ratio = 1.9, p = 0.001) and chronic kidney disease (CKD) (ratio = 1.4, p = 0.019). The presence and severity of DR was associated with increased direct medical costs in T2DM. Our results suggest that preventing progression of DR may reduce the economic burden of DR.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0180949（source: https://plos.figshare.com/articles/dataset/Direct_medical_cost_associated_with_diabetic_retinopathy_severity_in_type_2_diabetes_in_Singapore/5192446）。